|
US5981485A
(en)
*
|
1997-07-14 |
1999-11-09 |
Genentech, Inc. |
Human growth hormone aqueous formulation
|
|
EP0934061B3
(en)
|
1996-07-24 |
2015-01-21 |
Warner-Lambert Company LLC |
Isobutylgaba and its derivatives for the treatment of pain
|
|
CN1278737A
(zh)
*
|
1997-11-12 |
2001-01-03 |
阿尔萨公司 |
减少多肽自结合的方法
|
|
GB9803448D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Pharma Mar Sa |
Pharmaceutical formulation
|
|
JP4711520B2
(ja)
*
|
2000-03-21 |
2011-06-29 |
日本ケミカルリサーチ株式会社 |
生理活性ペプチド含有粉末
|
|
TWI283182B
(en)
|
2000-08-07 |
2007-07-01 |
Nektar Therapeutics |
Inhalable spray dried 4-helix bundle protein powders having minimized aggregation
|
|
JP4949828B2
(ja)
*
|
2003-03-18 |
2012-06-13 |
アレス トレーディング ソシエテ アノニム |
溶液中での成長ホルモンの安定化
|
|
AU2004224439B2
(en)
*
|
2003-03-24 |
2010-07-15 |
Genzyme Corporation |
Temporary embolization using inverse thermosensitive polymers
|
|
DE10333317A1
(de)
|
2003-07-22 |
2005-02-17 |
Biotecon Therapeutics Gmbh |
Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA)
|
|
WO2005046438A2
(en)
*
|
2003-11-06 |
2005-05-26 |
Pluromed, Inc. |
Internal clamp for surgical procedures
|
|
US8338374B2
(en)
*
|
2003-12-23 |
2012-12-25 |
Pharmacia Corporation |
Stable growth hormone liquid formulation
|
|
AU2005237775B2
(en)
*
|
2004-04-07 |
2010-03-04 |
Ares Trading S.A. |
Liquid growth hormone formulation
|
|
SG160437A1
(en)
*
|
2004-12-22 |
2010-04-29 |
Ambrx Inc |
Modified human growth hormone
|
|
CN101374536B
(zh)
*
|
2004-12-22 |
2013-09-25 |
Ambrx公司 |
包含非天然编码的氨基酸的人生长激素配方
|
|
EP1833993A4
(en)
*
|
2004-12-22 |
2009-07-22 |
Ambrx Inc |
HUMAN GROWTH HORMONE FORMULATIONS COMPRISING AN AMINO ACID CODED NON-NATURALLY
|
|
RU2008105545A
(ru)
|
2005-08-30 |
2009-10-10 |
Ново Нордиск Хелс Кеа Аг (Ch) |
Жидкие препараты пэгилированного гормона роста
|
|
WO2007033427A1
(en)
*
|
2005-09-23 |
2007-03-29 |
Metabolic Pharmaceuticals Limited |
Stabilisation of peptides with basic amino acids
|
|
CN1939534B
(zh)
*
|
2005-09-27 |
2010-12-01 |
长春金赛药业股份有限公司 |
含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
|
|
EP2049148B1
(en)
*
|
2006-07-06 |
2016-09-28 |
Daewoong Co., Ltd. |
A stable liquid formulation of human growth hormone
|
|
CN101495155A
(zh)
|
2006-07-07 |
2009-07-29 |
诺沃-诺迪斯克保健股份有限公司 |
新的蛋白结合物及其制备方法
|
|
DK2486916T3
(en)
*
|
2006-12-18 |
2015-06-15 |
Ajinomoto Althea Inc |
Formulations of Human Growth Hormone
|
|
AU2011208620B2
(en)
|
2010-01-22 |
2015-04-16 |
Novo Nordisk Health Care Ag |
Stable growth hormone compounds
|
|
TWI508737B
(zh)
|
2010-01-22 |
2015-11-21 |
諾佛 儂迪克股份有限公司 |
具有延長的活體內功效的生長激素
|
|
KR101337797B1
(ko)
*
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
WO2012038822A1
(en)
*
|
2010-09-21 |
2012-03-29 |
Ferring B.V. |
Improved process for production of recombinant human growth hormone
|
|
US9216219B2
(en)
|
2012-06-12 |
2015-12-22 |
Novartis Ag |
Anti-BAFFR antibody formulation
|
|
CA2880896C
(en)
|
2012-06-26 |
2021-11-16 |
Del Mar Pharmaceuticals |
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or ahi1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
|
|
WO2014166836A1
(en)
|
2013-04-05 |
2014-10-16 |
Novo Nordisk A/S |
Growth hormone compound formulation
|
|
US11491154B2
(en)
|
2013-04-08 |
2022-11-08 |
Dennis M. Brown |
Therapeutic benefit of suboptimally administered chemical compounds
|
|
WO2015013579A1
(en)
|
2013-07-26 |
2015-01-29 |
Update Pharma Inc. |
Compositions to improve the therapeutic benefit of bisantrene
|
|
AU2014329003A1
(en)
*
|
2013-09-27 |
2016-05-12 |
Hanmi Pharm. Co., Ltd. |
A formulation of long-acting human growth hormone conjugate
|
|
US9119832B2
(en)
|
2014-02-05 |
2015-09-01 |
The Regents Of The University Of California |
Methods of treating mild brain injury
|
|
US20170121385A1
(en)
|
2015-10-28 |
2017-05-04 |
Oxeia Biopharmaceuticals, Inc. |
Methods of treating neurodegenerative conditions
|
|
SMT202300480T1
(it)
|
2016-03-28 |
2024-01-10 |
Incyte Corp |
Composti di pirrolotriazina come inibitori di tam
|
|
CN111278453A
(zh)
|
2017-09-07 |
2020-06-12 |
Jcr制药股份有限公司 |
水性药物组合物
|
|
TWI821200B
(zh)
|
2017-09-27 |
2023-11-11 |
美商英塞特公司 |
Tam抑制劑之鹽
|
|
PT3813800T
(pt)
|
2018-06-29 |
2025-06-06 |
Incyte Corp |
Formulações de um inibidor de axl/mer
|
|
AU2021230385A1
(en)
|
2020-03-06 |
2022-09-22 |
Incyte Corporation |
Combination therapy comprising AXL/MER and PD-1/PD-L1 inhibitors
|
|
CN115634284B
(zh)
*
|
2022-10-31 |
2025-02-11 |
景泽生物医药(合肥)股份有限公司 |
一种促性腺激素冻干制剂及其制备方法
|